Publication | Open Access

Design, synthesis and molecular docking study of novel quinoxalin-2(1H)-ones as anti-tumor active agents with inhibition of tyrosine kinase receptor and studying their cyclooxygenase-2 activity

Medicinal ChemistryNovel Quinoxalin-2MedicineNatural SciencesMechanism Of ActionPharmacotherapyAnti-cancer AgentDrug DevelopmentChemical BiologyPharmacologyRadiation OncologyTyrosine Kinase ReceptorMolecular Docking StudyDrug Discovery